FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
BUTAZOLIDIN
phenylbutazone
LOE Approaching
Novartis
ORAL · CAPSULE
1997
NDA30/100
BUTISOL SODIUM
butabarbital sodium
LOE Approaching
ORAL · TABLET
1939
NDA30/100
BUTOCONAZOLE NITRATE
butoconazole nitrate
LOE Approaching
Design Pharmaceuticals
VAGINAL · CREAM
1997
NDA30/100
BUTRANS
buprenorphine
LOE Approaching
Purdue Pharma
TRANSDERMAL · FILM, EXTENDED RELEASE
severepersistent pain+1
2010
NDA30/100
BYETTA
exenatide synthetic
LOE Approaching
SUBCUTANEOUS · INJECTABLE
type 2 diabetes mellitus
2009
PeptideNDA30/100
BYETTA
exenatide
LOE Approaching
AstraZeneca
SUBCUTANEOUS · INJECTABLE
type 2 diabetes mellitus
2005
PeptideNDA30/100
BYSTOLIC
nebivolol hydrochloride
LOE Approaching
AbbVie
ORAL · TABLET
hypertensionto lower blood pressure+1
2007
NDA30/100
CADUET
amlodipine and atorvastatin
LOE Approaching
Pfizer
ORAL · TABLET
hypertensionto lower blood pressure+8
2004
SMNDA30/100
CAFCIT
caffeine citrate
LOE Approaching
Hikma
INTRAVENOUS · SOLUTION
apnea of prematurity
1999
NDA30/100
CAFERGOT
caffeine; ergotamine tartrate
LOE Approaching
Novartis
ORAL · TABLET
1948
NDA30/100
CAFERGOT
caffeine; ergotamine tartrate
LOE Approaching
Novartis
RECTAL · SUPPOSITORY
1953
NDA30/100
CALAN
verapamil hydrochloride
LOE Approaching
Pfizer
ORAL · TABLET
hypertensionto lower blood pressure+1
1984
NDA30/100
CALAN
verapamil hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
hypertensionto lower blood pressure+1
1984
NDA30/100
CALAN SR
verapamil hydrochloride
LOE Approaching
Pfizer
ORAL · TABLET, EXTENDED RELEASE
hypertensionto lower blood pressure+1
1986
NDA30/100
CALCIBIND
cellulose sodium phosphate
LOE Approaching
Mission Therapeutics
ORAL · POWDER
1982
NDA30/100
CALCIJEX
calcitriol
LOE Approaching
AbbVie
INJECTION · INJECTABLE
the management of secondary hyperparathyroidismresultant metabolic bone disease in patients with moderate to severe chronic renal failure (C cr 15 to 55 mL/min) not yet on dialysis+5
1986
NDA30/100
CALCIMAR
calcitonin salmon
LOE Approaching
Sanofi
INJECTION · INJECTABLE
symptomatic Paget's disease of bone in patients with moderate to severe disease characterized by polyostotic involvement with elevated serum alkaline phosphataseurinary hydroxyproline excretion+2
1978
NDA30/100
CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER
calcium chloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
2000
NDA30/100
CALCIUM DISODIUM VERSENATE
edetate calcium disodium
LOE Approaching
Bausch + Lomb
INJECTION · INJECTABLE
blood levelsdepot stores of lead in lead poisoning (acute+3
1953
NDA30/100
CALDEROL
calcifediol
LOE Approaching
Merck & Co.
ORAL · CAPSULE
secondary hyperparathyroidism in adult patients with stage 34 chronic kidney disease+6
1980
NDA30/100
CALOMIST
cyanocobalamin
LOE Approaching
Pfizer
NASAL · SPRAY, METERED
anemia
2007
NDA30/100
CAMPRAL
acamprosate calcium
LOE Approaching
Forest Devices
ORAL · TABLET, DELAYED RELEASE
2004
NDA30/100
CAMPTOSAR
irinotecan hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1996
NDA30/100
CANCIDAS
caspofungin acetate
LOE Approaching
Merck & Co.
INTRAVENOUS · POWDER
the following candida infections: intra-abdominal abscessesperitonitis+6
2001
NDA30/100